Filing Flows › AvePoint (AVPT) › R&D spending
AvePoint (AVPT) R&D spending by quarter
AvePoint's R&D spending was $16.2M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $12.7M (Q1 2025) to $16.6M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $16.2M | -2% | +16% |
| Q2 2026 | $16.6M | +20% | +28% |
| Q1 2026 | $13.8M | +6% | +8% |
| Q4 2025 | $13.0M | -7% | — |
| Q3 2025 | $13.9M | +8% | — |
| Q2 2025 | $13.0M | +2% | — |
| Q1 2025 | $12.7M | — | — |
Q3 2026 at a glance
AvePoint, Q3 2026: revenue $131M (+20% year over year), operating margin 8.7%, net earnings $17.9M, operating cash flow $31.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is AvePoint's R&D spending?
AvePoint's R&D spending was $16.2M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has AvePoint's R&D spending changed?
Over the last 7 quarters it ranged from $12.7M (Q1 2025) to $16.6M (Q2 2026).